Shen BQ - Search Results

1

Quantitative cumulative biodistribution of antibodies in mice: effect of modulating binding affinity to the neonatal Fc receptor.

Yip V, Palma E, Tesar DB, Mundo EE, Bumbaca D, Torres EK, Reyes NA, Shen BQ, Fielder PJ, Prabhu S, Khawli LA, Boswell CA. Yip V, et al. Among authors: shen bq. MAbs. 2014 May-Jun;6(3):689-96. doi: 10.4161/mabs.28254. Epub 2014 Feb 26. MAbs. 2014. PMID: 24572100 Free PMC article.

2

Real-time quantification of antibody-short interfering RNA conjugate in serum by antigen capture reverse transcription-polymerase chain reaction.

Tan M, Vernes JM, Chan J, Cuellar TL, Asundi A, Nelson C, Yip V, Shen B, Vandlen R, Siebel C, Meng YG. Tan M, et al. Anal Biochem. 2012 Nov 15;430(2):171-8. doi: 10.1016/j.ab.2012.08.018. Epub 2012 Aug 26. Anal Biochem. 2012. PMID: 22929697 Review.

3

Characterization of intact antibody-drug conjugates from plasma/serum in vivo by affinity capture capillary liquid chromatography-mass spectrometry.

Xu K, Liu L, Saad OM, Baudys J, Williams L, Leipold D, Shen B, Raab H, Junutula JR, Kim A, Kaur S. Xu K, et al. Anal Biochem. 2011 May 1;412(1):56-66. doi: 10.1016/j.ab.2011.01.004. Epub 2011 Jan 7. Anal Biochem. 2011. PMID: 21216214

4

Monomethyl Auristatin E (MMAE), a Payload for Multiple Antibody Drug Conjugates (ADCs), Demonstrates Differential Red Blood Cell Partitioning Across Human and Animal Species.

Yip V, Saad OM, Leipold D, Li C, Kamath A, Shen BQ. Yip V, et al. Among authors: shen bq. Xenobiotica. 2024 Apr 22:1-13. doi: 10.1080/00498254.2024.2345849. Online ahead of print. Xenobiotica. 2024. PMID: 38647387

5

Widespread latent hyperactivity of nociceptors outlasts enhanced avoidance behavior following incision injury.

Bavencoffe AG, Lopez ER, Johnson KN, Tian J, Gorgun FM, Shen BQ, Zhu MX, Dessauer CW, Walters ET. Bavencoffe AG, et al. Among authors: shen bq. bioRxiv [Preprint]. 2024 Jan 31:2024.01.30.578108. doi: 10.1101/2024.01.30.578108. bioRxiv. 2024. PMID: 38352319 Free PMC article. Preprint.

6

Clinical pharmacology strategies to accelerate the development of polatuzumab vedotin and summary of key findings.

Liao MZ, Lu D, Lu T, Gibiansky L, Deng R, Samineni D, Dere R, Lin A, Hirata J, Shen BQ, Zhang D, Li D, Li C, Miles D. Liao MZ, et al. Among authors: shen bq. Adv Drug Deliv Rev. 2024 Apr;207:115193. doi: 10.1016/j.addr.2024.115193. Epub 2024 Feb 3. Adv Drug Deliv Rev. 2024. PMID: 38311111 Free article. Review.

7

Utilizing PK and PD Biomarkers to Guide the First-in-Human Starting Dose Selection of MTBT1466A: A Novel Humanized Monoclonal Anti-TGFβ3 Antibody for the Treatment of Fibrotic Diseases.

Yadav R, Sukumaran S, Lutman J, Mitra MS, Halpern W, Sun T, Setiadi AF, Neighbors M, Sheng XR, Yip V, Shen BQ, Liu C, Han L, Ovacik AM, Wu Y, Glickstein S, Kunder R, Arron JR, Pan L, Kamath AV, Stefanich EG. Yadav R, et al. Among authors: shen bq. J Pharm Sci. 2023 Nov;112(11):2910-2920. doi: 10.1016/j.xphs.2023.07.005. Epub 2023 Jul 8. J Pharm Sci. 2023. PMID: 37429356 Free article.

8

Sex-differences in prostaglandin signaling: a semi-systematic review and characterization of PTGDS expression in human sensory neurons.

Shen BQ, Sankaranarayanan I, Price TJ, Tavares-Ferreira D. Shen BQ, et al. Sci Rep. 2023 Mar 22;13(1):4670. doi: 10.1038/s41598-023-31603-x. Sci Rep. 2023. PMID: 36949072 Free PMC article.

9

A homogeneous high-DAR antibody-drug conjugate platform combining THIOMAB antibodies and XTEN polypeptides.

Zacharias N, Podust VN, Kajihara KK, Leipold D, Del Rosario G, Thayer D, Dong E, Paluch M, Fischer D, Zheng K, Lei C, He J, Ng C, Su D, Liu L, Masih S, Sawyer W, Tinianow J, Marik J, Yip V, Li G, Chuh J, Morisaki JH, Park S, Zheng B, Hernandez-Barry H, Loyet KM, Xu M, Kozak KR, Phillips GL, Shen BQ, Wu C, Xu K, Yu SF, Kamath A, Rowntree RK, Reilly D, Pillow T, Polson A, Schellenberger V, Hazenbos WLW, Sadowsky J. Zacharias N, et al. Among authors: shen bq. Chem Sci. 2022 Jan 28;13(11):3147-3160. doi: 10.1039/d1sc05243h. eCollection 2022 Mar 16. Chem Sci. 2022. PMID: 35414872 Free PMC article.

10

Trastuzumab does not bind rat or mouse ErbB2/neu: implications for selection of non-clinical safety models for trastuzumab-based therapeutics.

Lewis Phillips G, Guo J, Kiefer JR, Proctor W, Bumbaca Yadav D, Dybdal N, Shen BQ. Lewis Phillips G, et al. Among authors: shen bq. Breast Cancer Res Treat. 2022 Jan;191(2):303-317. doi: 10.1007/s10549-021-06427-w. Epub 2021 Oct 27. Breast Cancer Res Treat. 2022. PMID: 34708303 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

68 results

Search Page